Cargando…
Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis
Patients with autoimmune disorders (AD) have altered cancer risks compared to the general population. Systemic lupus erythematosus and multiple sclerosis lead to a heightened risk for hematological malignancies and decreased risk for breast, ovarian, and prostate malignancies. Often patients with au...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822541/ https://www.ncbi.nlm.nih.gov/pubmed/33481783 http://dx.doi.org/10.1371/journal.pone.0243150 |
_version_ | 1783639663343304704 |
---|---|
author | Johnson, Deborah K. Reynolds, Kaylia M. Poole, Brian D. Montierth, Matthew D. Todd, Vera M. Barnado, April Davis, Mary F. |
author_facet | Johnson, Deborah K. Reynolds, Kaylia M. Poole, Brian D. Montierth, Matthew D. Todd, Vera M. Barnado, April Davis, Mary F. |
author_sort | Johnson, Deborah K. |
collection | PubMed |
description | Patients with autoimmune disorders (AD) have altered cancer risks compared to the general population. Systemic lupus erythematosus and multiple sclerosis lead to a heightened risk for hematological malignancies and decreased risk for breast, ovarian, and prostate malignancies. Often patients with autoimmune disease have dysregulated antiviral immune responses, including against oncogenic viruses. To uncover the relationship between viral incidence and cancer risk in the context of autoimmune disease, we extracted electronic health records (EHR) from Vanderbilt University. ICD-9/10 codes and laboratory values were collected for hematological, lung, anal-vaginal, thyroid, hepatobiliary, bladder, prostate, and breast cancers; and viruses including Epstein Barr virus (EBV), Human papilloma virus (HPV), and Hepatitis A/B/C (Hep). Only viral infections that led to a physician visit or laboratory test were entered into the EMR; therefore, only clinically relevant cases were noted and considered positive in this study. The relationship between virus infection and cancer in an SLE cohort (SLE-cases n = 2,313, and SLE-controls n = 5,702) and an MS cohort (MS-case n = 7,277, MS-control n = 7,277) was examined by multilinear logistic regression. Viral infection was strongly associated with increased risk for cancer overall. SLE and MS patients were more susceptible to all viral infections. MS patients trended toward increased risk for cancers overall, while decreased risk for hormone-based cancers in SLE patients non-significantly reduced their risk for overall cancer. Both SLE and MS patients had increased clinically relevant EBV infection, which was associated with risk for hematological cancers. Preventing viral infections by vaccination may be especially helpful in controlling risk for cancer in SLE and MS patients. |
format | Online Article Text |
id | pubmed-7822541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-78225412021-02-01 Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis Johnson, Deborah K. Reynolds, Kaylia M. Poole, Brian D. Montierth, Matthew D. Todd, Vera M. Barnado, April Davis, Mary F. PLoS One Research Article Patients with autoimmune disorders (AD) have altered cancer risks compared to the general population. Systemic lupus erythematosus and multiple sclerosis lead to a heightened risk for hematological malignancies and decreased risk for breast, ovarian, and prostate malignancies. Often patients with autoimmune disease have dysregulated antiviral immune responses, including against oncogenic viruses. To uncover the relationship between viral incidence and cancer risk in the context of autoimmune disease, we extracted electronic health records (EHR) from Vanderbilt University. ICD-9/10 codes and laboratory values were collected for hematological, lung, anal-vaginal, thyroid, hepatobiliary, bladder, prostate, and breast cancers; and viruses including Epstein Barr virus (EBV), Human papilloma virus (HPV), and Hepatitis A/B/C (Hep). Only viral infections that led to a physician visit or laboratory test were entered into the EMR; therefore, only clinically relevant cases were noted and considered positive in this study. The relationship between virus infection and cancer in an SLE cohort (SLE-cases n = 2,313, and SLE-controls n = 5,702) and an MS cohort (MS-case n = 7,277, MS-control n = 7,277) was examined by multilinear logistic regression. Viral infection was strongly associated with increased risk for cancer overall. SLE and MS patients were more susceptible to all viral infections. MS patients trended toward increased risk for cancers overall, while decreased risk for hormone-based cancers in SLE patients non-significantly reduced their risk for overall cancer. Both SLE and MS patients had increased clinically relevant EBV infection, which was associated with risk for hematological cancers. Preventing viral infections by vaccination may be especially helpful in controlling risk for cancer in SLE and MS patients. Public Library of Science 2021-01-22 /pmc/articles/PMC7822541/ /pubmed/33481783 http://dx.doi.org/10.1371/journal.pone.0243150 Text en © 2021 Johnson et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Johnson, Deborah K. Reynolds, Kaylia M. Poole, Brian D. Montierth, Matthew D. Todd, Vera M. Barnado, April Davis, Mary F. Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis |
title | Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis |
title_full | Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis |
title_fullStr | Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis |
title_full_unstemmed | Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis |
title_short | Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis |
title_sort | contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822541/ https://www.ncbi.nlm.nih.gov/pubmed/33481783 http://dx.doi.org/10.1371/journal.pone.0243150 |
work_keys_str_mv | AT johnsondeborahk contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis AT reynoldskayliam contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis AT poolebriand contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis AT montierthmatthewd contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis AT toddveram contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis AT barnadoapril contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis AT davismaryf contributionofviralinfectiontoriskforcancerinsystemiclupuserythematosusandmultiplesclerosis |